The accompanying notes are an integral part of the condensed
financial statements.
NOTES TO CONDENSED FINANCIAL STATEMENTS (unaudited)
NOTE 1 - BASIS OF PRESENTATION
The accompanying unaudited financial
statements were prepared in accordance with instructions for Form 10-Q and, therefore, do not include information or
footnotes necessary for a complete presentation of financial condition, results of operations, and cash flows in conformity
with U.S. Generally Accepted Accounting Principles US GAAP. All adjustments, consisting of normal recurring accruals, which,
in the opinion of management, are necessary for fair presentation of the financial statements, have been included. The
results of operations for the period ended September 30, 2011, are not necessarily indicative of the results which may be
expected for the entire fiscal year or for any other period. For further information, refer to the financial statements and
footnotes thereto for the year ended December 31, 2010 included in PureSpectrum Inc.’s Form 10-K.
Certain prior year amounts have been reclassified to conform to the 2011 presentation.
NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS
The Company’s management does not believe that recent codified pronouncements by the Financial Accounting Standards Board FASB will have a material impact on the Company’s current or future financial statements.
NOTE 3 - SUMMARY OF ORGANIZATION
PureSpectrum, Inc. (the “Company”), formerly International Medical Staffing, Inc., is a Delaware corporation incorporated on March 21, 2007. The Company is in the business of developing, marketing, licensing, and contract manufacturing of lighting technology for use in residential, commercial, and industrial applications worldwide.
The Company is authorized to issue
950 million shares, consisting of (a) 900 million shares of common stock, par value $0.0001 per share and (b) 50 million
shares of preferred stock, par value $0.0001 per share, which may be issuable in one or more series. Each common share is
entitled to one vote and shareholders have no preemptive or conversion rights. As of September 30, 2011, and December
31, 2010, there were 876,368,278 and 351,691,363 common shares issued and outstanding, respectively. The Company’s
Board of Directors may, without further action by the shareholders, direct the issuance of preferred stock for any proper
corporate purpose with preferences, voting powers, conversion rights, qualifications, special or relative rights and
privileges which could adversely affect the voting power or other rights of shareholders of common stock. As of September 30,
2011, and December 31, 2010, there were 2,000,000 and 2,000,000 shares of the Company’s preferred stock issued or
outstanding, respectively. Each Series B preferred share entitles the holder thereof to five hundred (500) votes per share
and may vote on any action requiring any class of shares to vote.
NOTE 4 – GOING CONCERN
The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses from operations of $1,194,384 for the Nine Months ended September 30, 2011. In addition, at September 30, 2011, the Company has an accumulated deficit of $23,378,478 and negative working capital of $3,253,297.
These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.
The Company recorded its first revenues in October 2009 and is no longer a development stage company. The Company has not yet generated sufficient working capital to support its operations. The Company’s ability to continue as a going concern is dependent, among other things, on its ability to minimize costs, enter into revenue generating contracts and obtain additional revenues to eventually attain a profitable level of operations.
The Company has been engaged in developing, marketing, licensing, and contract manufacturing of fluorescent lighting technology for use in residential, commercial, and industrial applications worldwide. There can be no assurance that the Company will be successful in the commercialization of the fluorescent lighting technology that will generate sufficient revenues to sustain the operations of the Company.
Management plans to obtain additional capital investments to enable the Company to continue operations and increase revenues in 2011. There is no assurance that management will be able to successfully generate revenue and/or reduce expenses sufficient to attain profitability, or continue to attract the capital necessary to support the business.
NOTE 5 - NET LOSS PER SHARE
Basic net loss per share is computed by dividing net loss attributable to commons shareholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common share equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, convertible preferred stock, stock options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.
NOTE 6 – NOTES PAYABLE
Notes payable consist of the following:
|
|
September 30, 2011
|
|
|
December 31, 2010
|
|
Note payable, unsecured, to shareholder at 5% interest, payable upon demand
|
|
|
61,650
|
|
|
|
61,650
|
|
Note payable, unsecured, to officer at 5% interest, payable upon demand
|
|
|
—
|
|
|
|
—
|
|
|
|
|
61,650
|
|
|
|
61,650
|
|
Less current portion
|
|
|
61,650
|
|
|
|
61,650
|
|
Long term portion
|
|
|
—
|
|
|
|
—
|
|
NOTE 7 – CONVERTIBLE NOTES AND DEBENTURES
PAYABLE
Convertible debt consists of the following:
|
|
September 30, 2011
|
|
|
December 31, 2010
|
|
Convertible notes issued to an investor, net of discount of $5,347 and $21,246 as of September 30, 2011 and December 31, 2010 respectively.
|
|
|
257,641
|
|
|
|
213,754
|
|
|
|
|
|
|
|
|
|
|
Convertible debentures issued to an investor, net of discount of $419,250 and $670,800 as of September 30, 2011 and December 31, 2010 respectively.
|
|
|
698,750
|
|
|
|
447,200
|
|
|
|
|
|
|
|
|
|
|
Convertible notes issued to an investor, net of discount of
$0 and $0 as of September 30, 2011 December 31, 2010 respectively.
|
|
|
174,452
|
|
|
|
162,582
|
|
|
|
|
|
|
|
|
|
|
Convertible notes issued to an investor, net of discount of
$0 and $0 as of September 30, 2011 December 31, 2010 respectively.
|
|
|
125,000
|
|
|
|
125,000
|
|
|
|
|
|
|
|
|
|
|
Convertible notes issued to an investor, net of discount of
$0 and $0 as of September 30, 2011 December 31, 2010 respectively.
|
|
|
178,265
|
|
|
|
15,204
|
|
|
|
|
|
|
|
|
|
|
Convertible notes issued to an investor, net of discount of
$0 and $0 as of September 30, 2011 December 31, 2010 respectively.
|
|
|
75,000
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
Convertible notes issued to an investor, net of discount of
$231 and $0 as of September 30, 2011 and December 31, 2010 respectively.
|
|
|
19,269
|
|
|
|
—
|
|
|
|
|
1,528,377
|
|
|
|
1,038,740
|
|
Less current portion
|
|
|
698,750
|
|
|
|
591,540
|
|
Long term portion
|
|
|
829,627
|
|
|
|
447,200
|
|
NOTE 8 – OPTIONS AND WARRANTS
Options and warrants generally vest immediately upon grant. The Company has historically issued warrants related to raising capital. As of September 30, 2011, the Company has 44,136,929 options outstanding and exercisable and 72,000,000 warrants outstanding and exercisable.
Information about stock options and warrants outstanding at September 30, 2011 and December 31, 2010 is summarized below:
|
|
Shares
|
|
|
Weighed Average Exercise
Price Per Share
|
|
|
Weighed Average Remaining
Contractual Life
|
|
|
|
|
Warrants
|
|
|
|
Stock
Options
|
|
|
|
Warrants
|
|
|
|
Stock
Options
|
|
|
|
Warrants
|
|
|
|
Stock
Options
|
|
Outstanding at December 31, 2010
|
|
|
72,000,000
|
|
|
|
44,136,929
|
|
|
|
0.750
|
|
|
|
0.060
|
|
|
|
3.2
|
|
|
|
3.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cancelled or Expired
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at September 30, 2011
|
|
|
72,000,000
|
|
|
|
44,136,929
|
|
|
|
0.750
|
|
|
|
0.060
|
|
|
|
2.7
|
|
|
|
2.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at September 30, 2011
|
|
|
72,000,000
|
|
|
|
44,136,929
|
|
|
|
0.750
|
|
|
|
0.060
|
|
|
|
2.7
|
|
|
|
2.8
|
|
NOTE 9 - OPERATING LEASES AND OTHER COMMITMENTS AND CONTINGENCIES
Rental of office space and data processing equipment under operating leases were approximately $6,000 and $78,752 for the Nine Months ended September 30, 2011 and 2010, respectively.
NOTE 10 - RELATED PARTY TRANSACTIONS
Not applicable
NOTE 11 - SUBSEQUENT EVENTS
On December 5, 2011, Barclay Lyons transferred the Series B preferred shares to OTC Ventures, Inc., an entity controlled by Cedric Atkinson, our new chief executive officer. As a result of the foregoing, Mr. Atkinson will now be able to elect the Company’s Board of Directors and approve any action requiring the vote of the holders of the Company’s common stock.
On December 5, 2011 Gregory Clements
tendered his resignation as an officer and director of the Company. There was no disagreement between the Company and Mr.
Clements regarding the Company’s operations or financial reporting.
Concurrently with his resignation, Mr. Clements appointed Cedric Atkinson to serve as the Company’s sole officer and director.